May WASDE, A North Dakota View and Weather

May 09, 2023

Here are the Top 5 things the DTN Newsroom is tracking for the week of May 7. Watch for coverage of these and other topics throughout the week on our subscription platforms as well as on DTNPF.com.

1. May Grains Report, WASDE on Friday: The latest World Agricultural Supply and Demand (WASDE) report drops at 11 a.m. CDT. This is the month when USDA shifts crop years, so there is typically a bit of adjusting to production numbers. DTN Lead Analyst Todd Hultman will have a report preview ahead of the actual report; he will hold an hour-long webinar discussing the report's effect on markets at 12:30 CDT on Friday. To register for the webinar, go here: https://www.dtn.com/….

2. Global water issues: Farm leaders from around the world are gathering in Lincoln, Nebraska for the 2023 Water For Food Global Conference. We'll cover the event which tackles issues around the ongoing conflict between urban and rural/farm uses of water, and the challenges brought on by climate change, soil degradation, water access and economic disparity.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.